Boehringer Ingelheim Office Hours in Vienna
In collaboration with LISAvienna, Boehringer Ingelheim invites the regional biomedical community to join personalized one-on-one consulting sessions. Apply by May 1, 2019 at the latest.
BI Office Hours offers life science companies and entrepreneurs individual attention in an informal ‘office hours’ atmosphere. Designed as a consultative ‘round table’ meeting, this pioneering mentoring initiative ‘lifts the lid’ on how a big pharma company works and it provides access to expertise, an industry perspective and feedback to emerging life-science businesses.
While deliberately not being a partnering meeting, BI Office Hours gives participants direct access to BI’s management and know-how (science and business) to find out what are the critical factors a pharma partner is looking for in terms of, for example, therapeutic concept validation, ‘key’ experiments, therapeutic modalities (small molecules, antibodies, others), animal models, patient selection biomarkers, clinical development, landscape positioning, and reimbursement considerations.
Apply for a meeting slot in Vienna soon
We would like to invite you to apply for the next BI Office Hours to be held on May 28th 2019, 09:00 - 17:00 at the Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, 1030 Vienna, Austria. In preparation for the discussion please kindly provide the BI team with:
- An executive summary and/or,
- A short presentation (no more than 10 slides) outlining your technology, main features, problems it solves and any supportive scientific data
- Please include 5 key questions you would like to have answered during the brainstorming session
All information submitted must be non-confidential and provided four weeks in advance of the event. The Boehringer Ingelheim team meets with only 5 companies in a day, with the intent of having a one-on-one informal conversation. Since starting this program Boehringer Ingelheim has coached >100 companies (in Boston, San Diego, UK and Vienna), all with very positive feedback.
E-mail your meeting requeest to Guido Boehmelt and Emilio Erazo-Fischer by May 1, 2019.
Guido Boehmelt
Research Beyond Borders
Boehringer Ingelheim RCV
Emilio Erazo-Fischer
Business Development & Licensing
Boehringer Ingelheim International GmbH